US FDA Generic Approvals Peak In April, But Annual Pace Trends Down

 
• By Derrick Gingery
FDA approved background, 3D rendering, blue street sign
While approvals may slip from last year's record-breaking tally, ANDA submissions remained on pace to slightly exceed the FY 2019 total, according to data through April. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics